urothelial carcinoma

Showing 1 - 25 of 174

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma Trial in Canton (ACR-368, Gemcitabine,

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Canton, Ohio
    Gabrail Cancer Center
Sep 16, 2022

Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Solid Tumor Trial (TYRA-300)

Not yet recruiting
  • Locally Advanced Urothelial Carcinoma
  • +3 more
  • (no location specified)
Sep 15, 2022

Atezolizumab in Ministry of Food and Drug Safety-Approved

Completed
  • Urothelial Carcinoma
  • +4 more
  • Busan, Korea, Republic of
  • +55 more
Aug 23, 2022

Urothelial Carcinoma Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Urothelial Carcinoma
  • Pembrolizumab
  • +2 more
  • Gilbert, Arizona
  • +193 more
Aug 22, 2022

Atezolizumab Under Real-World Conditions in Patients Treated in

Recruiting
  • Urothelial Carcinoma
  • +3 more
  • Buenos Aires, Argentina
  • +314 more
Aug 22, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Urothelial Carcinoma Trial in Worldwide (Rogaratinib (BAY1163877), Atezolizumab)

Active, not recruiting
  • Urothelial Carcinoma
  • Tucson, Arizona
  • +29 more
Aug 17, 2022

Urothelial Carcinoma Trial in United States (disitamab vedotin, pembrolizumab)

Recruiting
  • Urothelial Carcinoma
  • Grand Rapids, Michigan
  • +3 more
Aug 15, 2022

Melanoma, Urothelial Carcinoma Trial in Berlin (Nivolumab/rHuPH20, Nivolumab)

Not yet recruiting
  • Melanoma
  • Urothelial Carcinoma
  • Berlin, Germany
    Local Institution - 0001
Aug 9, 2022

Urothelial Cancer of Renal Pelvis, Urothelial Carcinoma of the Renal Pelvis and Ureter, Urothelial Carcinoma Ureter Trial

Available
  • Urothelial Cancer of Renal Pelvis
  • +5 more
  • Mitomycin for pyelocalyceal solution
  • (no location specified)
Aug 5, 2022

NSCLC, Urothelial Carcinoma Trial in Worldwide (Durvalumab)

Enrolling by invitation
  • Non-Small Cell Lung Cancer
  • Urothelial Carcinoma
  • Newmarket, Ontario, Canada
  • +26 more
Aug 2, 2022

Urothelial Carcinoma Trial in Amsterdam, Nijmegen (Nivolumab)

Recruiting
  • Urothelial Carcinoma
  • Amsterdam, Netherlands
  • +1 more
Jul 28, 2022

Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)

Active, not recruiting
  • Melanoma
  • +27 more
  • XmAb20717
  • Los Angeles, California
  • +16 more
Jul 21, 2022

Learn About First-line Avelumab Maintenance in Japanese Locally

Not yet recruiting
  • Urothelial Carcinoma
  • Nagoya, Aichi, Japan
  • +14 more
Jul 21, 2022

Urothelial Carcinoma Trial in Beijing (18F-FDG)

Recruiting
  • Urothelial Carcinoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 18, 2022

Non Small Cell Lung Cancer, Cutaneous Melanoma, Head and Neck Squamous Cell Carcinoma Trial in United States (RTX-224)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Scottsdale, Arizona
  • +4 more
Jul 18, 2022

Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma Trial in United States

Active, not recruiting
  • Non-small-cell Lung Cancer
  • +5 more
  • PF-07209960
  • Duarte, California
  • +11 more
Jul 14, 2022

Urothelial Carcinoma Trial in Worldwide (Atezolizumab, Carboplatin, Gemcitabine)

Active, not recruiting
  • Urothelial Carcinoma
  • Springdale, Arkansas
  • +223 more
Jul 15, 2022

Urothelial Carcinoma Trial in Sohag (Expression of Cortactin anti body)

Completed
  • Urothelial Carcinoma
  • Expression of Cortactin anti body
  • Sohag, Egypt
    Maisa Hashem Mohammed
Jul 13, 2022

Bladder Cancer, Urothelial Carcinoma, Urothelial Carcinoma Bladder Trial in Worldwide (UGN-102)

Recruiting
  • Bladder Cancer
  • +2 more
  • Tucson, Arizona
  • +76 more
Jul 13, 2022

Urothelial Carcinoma Trial in Irvine, Dallas, Houston (MRx0518, Avelumab 20 mg/mL Intravenous Solution (IV))

Active, not recruiting
  • Urothelial Carcinoma
  • MRx0518
  • Avelumab 20 mg/mL Intravenous Solution (IV)
  • Irvine, California
  • +2 more
Jul 5, 2022

Muscle Invasive Bladder Carcinoma, Localized Cancer, Urothelial Carcinoma Trial (Pembrolizumab)

Not yet recruiting
  • Muscle Invasive Bladder Carcinoma
  • +2 more
  • (no location specified)
Jun 23, 2022